Showing results (91-100 of 277) with videos related to
Sort By:
Pageof 28
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2009
Phase I study of the c-raf-1 antisense oligonucleotide ISIS 5132 in combination with carboplatin and paclitaxel in patients with previously untreated, advanced non-small cell lung cancerPanos Fidias, Nathan A Pennell, Anthony L Boral, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2014
NUT midline carcinoma: an aggressive intrathoracic neoplasmSameer A Parikh, Christopher A French, Brian A Costello, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2016
Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid TumorsVandana G Abramson, Jeffrey G Supko, Tarah Ballinger, et al.Proceedings of the National Academy of Sciences of the United States of America|November 15, 2024
PARG inhibitor sensitivity correlates with accumulation of single-stranded DNA gaps in preclinical models of ovarian cancerRamya Ravindranathan, Ozge Somuncu, Alexandre André B A da Costa, et al.Cancer Research|February 12, 2004
The role of metastasis-associated protein 1 in prostate cancer progressionMatthias D Hofer, Rainer Kuefer, Sooryanarayana Varambally, et al.Future Oncology (London, England)|November 29, 2019
Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancerJeffrey W Clark, D Ross Camidge, Eunice L Kwak, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2020
Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non-Small Cell Lung CancerBiagio Ricciuti, Gonzalo Recondo, Liam F Spurr, et al.Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBMW Ruprecht Wiedemeyer, Ian F Dunn, Steven N Quayle, et al.Investigational New Drugs|April 21, 2015
A phase 1 study of ABT-806 in subjects with advanced solid tumorsJames M Cleary, David A Reardon, Nilofer Azad, et al.The Oncologist|February 16, 2018
Cabozantinib in Patients with Advanced Merkel Cell CarcinomaGuilherme Rabinowits, Cecilia Lezcano, Paul J Catalano, et al.Pageof 28